skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 158421 Add to Shopping cart Find in a Library
Title: Federal Employee Drug Testing
Author(s): L N Stevens
Corporate Author: US Government Accountability Office
General Government Division
United States of America
Date Published: 1988
Page Count: 12
Sponsoring Agency: Azimuth Inc.
Fairmont, WV 26554
US Government Accountability Office
Washington, DC 20548
Publication Number: GAO/T-GGD-88-40
Sale Source: Azimuth Inc.
1000 Technology Drive, Suite 3120
Fairmont, WV 26554
United States of America
Type: Legislative Hearing/Committee Report
Language: English
Country: United States of America
Annotation: The General Accounting Office reviewed Federal agency drug- testing plans submitted to Congress in accordance with Section 503 of the Supplemental Appropriations Act of 1987, Public Law 100-71.
Abstract: Based on a review of the drug-testing plans prepared by civilian Cabinet-level agencies and cost estimates prepared by the Office of Management and Budget (OMB), the study identified several areas of concern regarding program uniformity, employee rights, program costs, and the need for continuing oversight of the drug-testing programs. The study found that agencies vary in the positions identified as subject to drug testing, the frequency of testing, and the drugs for which employees are tested. Consequently, a uniform set of testing criteria will not be applied to the Federal workforce. Agency plans do not detail certain aspects of employee rights and agency disciplinary actions. The plans restrict applicant access to relevant drug test records and do not provide guidance on procedures to follow if an applicant chooses to challenge drug-test results. OMB cost estimates show notable variances among the agencies, and no provision exists for centralized, continuing oversight of the drug-testing programs.
Main Term(s): Employee drug testing
Index Term(s): Federal government; Substance abuse in the workplace
Note: DCC
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.